Your Article Summary
See Latest ArticlesCardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder
The Journal of Pediatrics, 07/01/09
Hammerness P et al. - Treatment with relatively high doses of OROS MPH was associated with small but statistically significant mean increases in BP and HR, primarily during the first 6 weeks of treatment, without clinically meaningful changes in ECG. These observations are consistent with previous reports using lower doses.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/23/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Today in Pediatric Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Ibuprofen and Ductus Arteriosus Closure in Full-Term Neonates: A Prospective Case-Control Study
Pediatric Cardiology, 10/30/09
Population-based analysis of sudden death in children: The Oregon Sudden Unexpected Death Study
Heart Rhythm, 11/04/09
Cardiac troponin-I as a screening tool for myocarditis in children hospitalized for viral infection
Acta Pediatrica, 11/16/09